Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Trovafloxacin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 1.00 |
| ▸ | HPGD | P15428 | 3/20 | 1.00 |
| ▸ | POLB | P06746 | 2/20 | 1.00 |
| ▸ | XBP1 | P17861 | 1/20 | 1.00 |
| ▸ | NFKB1 | P19838 | 1/20 | 1.00 |
| ▸ | HTT | P42858 | 1/20 | 1.00 |
| ▸ | NFKB2 | Q00653 | 1/20 | 1.00 |
| ▸ | RELA | Q04206 | 1/20 | 1.00 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.90 |
| ▸ | FLT4 | P35916 | 1/20 | 0.90 |
| ▸ | GSK3B | P49841 | 1/20 | 0.90 |
| ▸ | RARB | P10826 | 1/20 | 0.90 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.90 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.90 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.70 |
| ▸ | DPP4 | P27487 | 6/20 | 0.51 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trovafloxacin SCHEMBL8963965 | 1.00 | LMNA (1.00) | LMNAKDM4EALDH1A1HSD17B10HPGD | |
| Trovafloxacin SCHEMBL29711203 | 1.00 | LMNA (1.00) | LMNAKDM4EALDH1A1HSD17B10HPGD | |
| Trovafloxacin SCHEMBL29711214 | 1.00 | LMNA (1.00) | LMNAKDM4EALDH1A1HSD17B10HPGD | |
| Trovafloxacin SCHEMBL2222007 | 1.00 | LMNA (1.00) | LMNAKDM4EALDH1A1HSD17B10HPGD | |
| Trovafloxacin SCHEMBL40874 | 1.00 | LMNA (1.00) | LMNAKDM4EALDH1A1HSD17B10HPGD | |
| Trovafloxacin SCHEMBL1229498 | 0.99 | LMNA (0.98) | LMNAKDM4EALDH1A1HSD17B10HPGD | |
| Trovafloxacin SCHEMBL1229500 | 0.99 | LMNA (0.98) | LMNAKDM4EALDH1A1HSD17B10HPGD | |
| Trovafloxacin SCHEMBL8561863 | 0.99 | LMNA (0.98) | LMNAKDM4EALDH1A1HSD17B10HPGD | |
| Trovafloxacin SCHEMBL9177464 | 0.95 | EPHA2 (1.00) | LMNAKDM4EALDH1A1HSD17B10HPGD | |
| Trovafloxacin SCHEMBL34466 | 0.95 | EPHA2 (1.00) | LMNAKDM4EALDH1A1HSD17B10HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 884 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4724049-A1 | MODIFIED RELEASE FILL COMPOSITIONS FOR DOSAGE FORMS AND METHODS OF PREPARATION AND USE THEREOF | Catalent Ontario Limited (CA) | 2026-04-15 | — | — | EP | claimed |
| EP-3452124-B1 | HEMOSTATIC DEVICES AND METHODS OF USE | MEDTRONIC INC (US) | 2025-10-08 | — | — | EP | claimed |
| EP-3452123-B1 | HEMOSTATIC DEVICES AND METHODS OF USE | MEDTRONIC INC (US) | 2025-09-24 | — | — | EP | claimed |
| EP-3230500-B1 | METHODS OF ORIENTING MULTIFILAMENT YARN AND MONOFILAMENTS OF POLY-4-HYDROXYBUTYRATE AND COPOLYMERS THEREOF | TEPHA INC (US) | 2025-06-18 | — | — | EP | claimed |
| WO-2024254056-A1 | MODIFIED RELEASE FILL COMPOSITIONS FOR DOSAGE FORMS AND METHODS OF PREPARATION AND USE THEREOF | CATALENT ONTARIO LIMITED (CA) | 2024-12-12 | — | — | WO | claimed |
| EP-3678715-B1 | CALENDERED SURGICAL MESHES COMPRISING POLYHYDROXYALKANOATES | TEPHA INC (US) | 2024-10-30 | — | — | EP | claimed |
| EP-4442767-A2 | METHODS FOR 3D PRINTING OF POLY-4-HYDROXYBUTYRATE | Tepha, Inc. (US) | 2024-10-09 | — | — | EP | claimed |
| EP-3802062-B1 | METHODS FOR 3D PRINTING OF POLY-4-HYDROXYBUTYRATE | TEPHA INC (US) | 2024-09-18 | — | — | EP | claimed |
| CN-117858696-A | Antibiotic pharmaceutical composition capable of subcutaneous administration | 上海宝济药业股份有限公司 | 2024-04-09 | — | — | CN | claimed |
| EP-3452122-B1 | HEMOSTATIC DEVICES AND METHODS OF USE | MEDTRONIC INC (US) | 2023-03-22 | — | — | EP | claimed |
| US-20040253314-A1 | Melt extrusion of salts of active ingredients | ROEHM GMBH (DE) | 2004-12-16 | — | — | US | claimed |
| EP-1357928-A2 | A NOVEL PHARMACEUTICAL COMPOUND AND METHODS OF MAKING AND USING SAME | New River Pharmaceuticals Inc. (US) | 2003-11-05 | — | — | EP | claimed |
| EP-1057828-B1 | Trovafloxacin oral suspensions | PFIZER PROD INC (US) | 2003-03-19 | — | — | EP | claimed |
| WO-2003020200-A2 | A NOVEL PHARMACEUTICAL COMPOUND AND METHODS OF MAKING AND USING SAME | NEW RIVER PHARMACEUTICALS INC. (US) | 2003-03-13 | — | — | WO | claimed |
| US-6514492-B1 | Taste masking of oral quinolone liquid preparations using ion exchange resins | SCHERING-PLOUGH VETERINARY CORPORATION | 2003-02-04 | — | — | US | claimed |
| US-6239141-B1 | ANTIBIOTIC | PFIZER INC. | 2001-05-29 | — | — | US | claimed |
| US-6187341-B1 | ACTIVE MATERIAL WITH LUBRICANTS | PFIZER INC. | 2001-02-13 | — | — | US | claimed |
| EP-1057828-A2 | Trovafloxacin oral suspensions | Pfizer Products Inc. (US) | 2000-12-06 | — | — | EP | claimed |
| CN-1227743-A | Trovafloxacin mesylate tablet | PFIZER PROD INC (US) | 1999-09-08 | — | — | CN | claimed |
| EP-0930068-A2 | Trovafloxacin mesylate tablet | Pfizer Products Inc. (US) | 1999-07-21 | — | — | EP | claimed |